Purchase Order 75N95025P00080

<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>

<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $24,999.10 firm fixed-price purchase order to Vizioli Omics to complete research and analysis leading to the submission of manuscripts for publication. The contract, which does not have a set-aside designation, has a period of performance through June 24, 2025. This award appears to be for a standalone project and is not associated with a larger contract vehicle.</p>

<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $183,731.46 firm-fixed-price purchase order contract to Oxford Stemtech LTD for scientific support services related to the generation and multiomics profiling of induced pluripotent stem cell-derived neuronal models. The contract does not have a set-aside designation, and the ultimate completion date is September 10, 2025. This contract award is not associated with a larger acquisition vehicle.</p>

<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $12,000.00 firm-fixed-price purchase order contract to Vivpro Corp, a self-certified small disadvantaged business, for subscription licenses. The contract has an ultimate completion date of June 24, 2025 and was awarded on June 13, 2024. This contract does not have a set-aside designation.</p>

The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a firm fixed-price purchase order contract to Lavision Biotec GMBH, a for-profit manufacturer located in Germany. The contract, valued at $342,183.61, does not have a set-aside designation. The contract was awarded on August 19, 2016, with an ultimate completion date of October 30, 2016. No further details about the specific products or services being provided under this contract were included in the information...

<p>The U.S. National Institute on Drug Abuse (NIDA), a civilian agency, has awarded a $27,000 firm-fixed-price purchase order contract to the Massachusetts Institute of Technology (MIT) for MWORKS CONSULTING &amp; DEVELOPMENT services. The contract period of performance is from September 20, 2024 to March 19, 2025, with a final completion date of March 19, 2025. This contract does not have a set-aside designation.</p>

The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work...

<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $2,451,736.00 cost-plus-fixed-fee contract to Medispin Inc., a small business, for R&amp;D in physical science. The 3-year contract (ultimate completion date of Nov 30, 2009) was awarded on Sep 22, 2006 under a total small business set-aside. The contract is for research and experimental development activities related to the agency's mission.</p>

The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $142,160 firm fixed price purchase order contract to Nordicneurolab, Inc., a for-profit medical device manufacturer, for the provision of visual systems. The contract has an ultimate completion date of August 11, 2029. This award did not involve any set-aside designations. Nordicneurolab has previously received several other prime contract awards from various federal agencies for medical equipment and related...

This federal contract award was granted by the National Institute on Drug Abuse (NIDA), a civilian agency, to Idea Bio-Medical LTD, a for-profit organization, on September 9, 2015. The contract has a firm fixed price of $122,500.00 and a completion date of October 30, 2015. No set-aside designation was used. The contract type is a purchase order and does not appear to be associated with a larger contract vehicle. The provided information does not indicate any major subcontractors or additional...